Drug Pipeline

Dex-Esk Clinical Trials

Name: Dex-Esk clinical trials — 3 active studies
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12

Active Studies

Recruiting

Top Sponsors

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-06-02	NCT07610343 Intranasal Dexmedetomidine-esketamine on Sleep and Cognition in Older Adults With…	Phase changed: ['NA'] -> ['PHASE4']
2026-06-02	NCT07610343 Intranasal Dexmedetomidine-esketamine on Sleep and Cognition in Older Adults With…	Primary endpoint(s) modified

New Trial Filings, Last 30 Days

First Posted	Trial	Phase	Status
2026-05-27	NCT07610343 Intranasal Dexmedetomidine-esketamine on Sleep and Cognition in Older Adults With…	Phase 4	Not Yet Recruiting

Active Studies by Phase

Phase 4

Active Trials

NCT ID	Title	Condition	Status
Phase 4
NCT07576517	Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After…	Older Patients	Not Yet Recruiting
NCT07576543	Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive…	Older Patients	Not Yet Recruiting
NCT07610343	Intranasal Dexmedetomidine-esketamine on Sleep and Cognition in Older Adults With…	Older Adults	Not Yet Recruiting

Sponsors Running Dex-Esk Trials

Peking University First Hospital (3)

Get alerts when Dex-Esk trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.